Abstracts tagged "Rheumatoid arthritis (RA)"

Abstract Number: 190 • 2013 ACR/ARHP Annual Meeting
A Meta-Analysis and Systematic Literature Review: Effect Of The Method Used To Measure Adherence In Rheumatoid Arthritis On Its Rate, and Evaluation Of Associated Factors
Anat Scheiman-Elazary¹, Cortney Shourt², M. Cameron Hay³ and Daniel Furst⁴, ¹Rheumatology, Rheumatology UCLA, Los Angeles, CA, ²Rheumatology UCLA, Los Angeles, CA, ³Anthropology Miami University, Oxford, OH, ⁴Rheumatology, David Geffen School of Medicine, UCLA, Los Angeles, CA
Background/Purpose: Adherence reported in the literature for RA varies widely (49.5-98%)1. This variability may result in part from different methods used to measure adherence. Our…
Abstract Number: 2486 • 2013 ACR/ARHP Annual Meeting
Clinical Performance Of 4 Methods For Detecting Latent Tuberculosis Infection (LTbI) In Patients With Active Chronic Inflammatory Arthritis Taking TNFα Blockers
Carina M F Gomes¹, Maria Teresa Terreri², Maria Isabel Pinto³, Karen Oseki³, Fernanda Spina⁴ and Marcelo M. Pinheiro⁵, ¹Rheumatology Division, Universidade Federal de São Paulo, Sao Paulo, Brazil, ²Pediatrics, Universidade Federal de São Paulo / UNIFESP, Sao Paulo, Brazil, ³Pediatrics, Universidade Federal de São Paulo, Sao Paulo, Brazil, ⁴Rheumatology Division, Universidade Federal de São Paulo Unifesp/EPM, Brazil, Universidade Federal de São Paulo, Sao Paulo, Brazil, ⁵Brazilian Registry of Spondyloarthritis, São Paulo, Brazil
Background/Purpose: About 5% of the Brazilian population has some chronic inflammatory arthropathy (CIA), including rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PA) and juvenile…
Abstract Number: 1942 • 2013 ACR/ARHP Annual Meeting
Ultrasound Shows Tenosynovitis to be Frequently Present as Well As Sensitive to Change in RA Patients On Biologic Medication
Hilde B. Hammer, Dept of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
Background/Purpose: Ultrasound (US) (grey scale (GS) and power Doppler (PD)) is a sensitive tool for examination of tenosynovitis in patients with rheumatoid arthritis (RA). The…
Abstract Number: 1226 • 2013 ACR/ARHP Annual Meeting
Adherence With Current Osteoporosis Treatment Guidelines Among Rheumatologists Caring For Patients With Rheumatoid Arthritis Using Items From The Fracture Risk Assessment Tool Score
Jennifer Watt¹, Andrew E. Thompson², Nicole G. H. Le Riche³ and Janet E. Pope⁴, ¹Medicine, University of Western Ontario, London, ON, Canada, ²Rheumatology, St. Josephs Health Ctr, London, ON, Canada, ³Department of Medicine, St. Joseph's Hospital, London, ON, Canada, ⁴Medicine, Divsion of Rheumatology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
Background/Purpose: To assess whether the Fracture Risk Assessment Tool (FRAX) score in patients with RA correlates with likelihood of osteoporosis (OP) prescription including drug treatment,…
Abstract Number: L12 • 2013 ACR/ARHP Annual Meeting
Cetrorelix, a Gonadotropin-Releasing Hormone Antagonist, Demonstrates Efficacy and Significantly Reduces Proinflammatory Cytokines in Patients with Active Longstanding Rheumatoid Arthritis with High Gonadotropin Levels: A Proof-of-Concept, Double-Blind, Randomized Trial
Anita Kåss^1,2, Ivana Hollan³, Peter Torjesen⁴, Hans Christian Gulseth⁵ and Øystein T. Førre⁶, ¹Faculty of Medicine, University of Oslo, Oslo, Norway, ²Dept. of Rheumatology, Betanien Hospital, Skien, Norway, ³Rheumatology, Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway, ⁴Department of Endocrinology, Oslo University Hospital, Oslo, Norway, ⁵Rheumatology, Betanien Hospital, Skien, Norway, ⁶Oslo University Hospital, Oslo, Norway
Background/Purpose: The pathogenesis of rheumatoid arthritis (RA) is unclear, and treatment options can be improved. Gonadotropin-releasing hormone (GnRH) stimulates immune responses (1). Inhibiting GnRH, by…
Abstract Number: 2637 • 2012 ACR/ARHP Annual Meeting
Cost-Effectiveness and Cost-Utility Analysis of Treat-to-Target Versus Usual Care in Early Rheumatoid Arthritis: Results of the Dutch Rheumatoid Arthritis Monitoring Registry
Marloes Vermeer¹, Wietske Kievit², Ina H. Kuper³, Annemarie Braakman-Jansen⁴, Hein J. Bernelot Moens⁵, Theo R. Zijlstra⁶, Alfons A. den Broeder⁷, Piet L.C.M. van Riel², Jaap Fransen² and Mart A.F.J. van de Laar¹, ¹University of Twente & Medisch Spectrum Twente, Enschede, Netherlands, ²Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ³Medisch Spectrum Twente, Enschede, Netherlands, ⁴Psychology & Communication, University of Twente, Enschede, Netherlands, ⁵Ziekenhuisgroep Twente, Hengelo, Netherlands, ⁶Isala Klinieken, Zwolle, Netherlands, ⁷Rheumatology, Maartenskliniek, Nijmegen, Netherlands
Cost-Effectiveness and Cost-Utility Analysis of Treat-to-Target Versus Usual Care in Early Rheumatoid Arthritis: Results of the Dutch Rheumatoid Arthritis Monitoring RegistryBackground/Purpose: Treat-to-target (T2T) has proven…
Abstract Number: 1819 • 2012 ACR/ARHP Annual Meeting
Predictors of Pneumococcal Vaccination in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus
Anna Gramling¹, Kaleb Michaud², Harlan Sayles³, Frederick Wolfe⁴ and Michelene Hearth-Holmes⁵, ¹Rheumatology, University of Nebraska Medical Center, Omaha, NE, ²Rheumatology, National Data Bank for Rheumatic Diseases & University of Nebraska Medical Center, Omaha, NE, ³Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, ⁴National Data Bank for Rheumatic Diseases, Wichita, KS, ⁵Internal Medicine/Rheumatology Division, University of Nebraska Medical Center, Omaha, NE
Background/Purpose: Patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are at high risk for serious infection, including those caused by Streptococcus pneumoniae. Administration…
Abstract Number: 1192 • 2012 ACR/ARHP Annual Meeting
IL-21 Regulates B Cell Proliferation and Differentiation in Rheumatoid Arthritis
Lingyun Sun, Rui Liu and Xia Li, Department of Rheumatology and Immunology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
Background/Purpose: Interleukin (IL)-21 is a member of type I cytokine family. Recent studies have indicated that IL-21 is an important regulator for human B cell…
Abstract Number: 417 • 2012 ACR/ARHP Annual Meeting
The Potential Role of PTPRD Gene Copy Number Variation in Susceptibility to Rheumatoid Arthritis
Seung Cheol Shim¹, Donghyuk Sheen², Mi Kyoung Lim¹ and Hyo Park¹, ¹Medicine, Eulji University Hospital, Daejeon, South Korea, ²Rheumatology, Eulji University Hospital, Daejeon, South Korea
Background/Purpose: Since it is important to explore genetic variations associated with rheumatoid arthritis (RA), genome-wide association studies (GWAS) have led to the identification of RA…
Abstract Number: 105 • 2012 ACR/ARHP Annual Meeting
Combined Synovial and Structural Ultrasound Score for the Diagnosis of RA
Gary A. Kunkel¹, Grant W. Cannon² and Daniel O. Clegg³, ¹Div of Rheumatology, George Wahlen Veterans Affairs Medical Center, Salt Lake City, UT, ²Division of Rheumatology, George E. Wahlen VA Medical Center, Salt Lake City, UT, ³Division of Rheumatology, George E. Wahlen Veteran Affairs Medical Center, Salt Lake City, UT
Background/Purpose: Current ultrasonographic scoring systems used to assess the degree of finger joint synovitis in rheumatoid arthritis (RA) are not designed for distinguishing healthy or…
Abstract Number: 2607 • 2012 ACR/ARHP Annual Meeting
Adherence to a Treat-to-Target Strategy in Early Rheumatoid Arthritis: Results of the Dutch Rheumatoid Arthritis Monitoring Remission Induction Cohort
Marloes Vermeer¹, Ina H. Kuper², Hein J. Bernelot Moens³, Monique Hoekstra⁴, Marcel D. Posthumus⁵, Piet L.C.M. van Riel⁶ and Mart A.F.J. van de Laar⁷, ¹University of Twente & Medisch Spectrum Twente, Enschede, Netherlands, ²Medisch Spectrum Twente, Enschede, Netherlands, ³Ziekenhuisgroep Twente, Hengelo, Netherlands, ⁴Isala Klinieken, Zwolle, Netherlands, ⁵Department of Rheumatology, University of Groningen, University Medical Center, Groningen, Netherlands, ⁶Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ⁷Rheumatology, University of Twente & Medisch Spectrum Twente, Enschede, Netherlands
Adherence to a Treat-to-Target Strategy in Early Rheumatoid Arthritis: Results of the Dutch Rheumatoid Arthritis Monitoring Remission Induction CohortBackground/Purpose: A treat-to-target (T2T) approach has proven…
Abstract Number: 1824 • 2012 ACR/ARHP Annual Meeting
Do Statins Reduce the Incidence of Connective Tissue Disease? A Retrospective Cohort Study
Thomas W. Schmidt¹, Daniel F. Battafarano¹, Christopher R. Frei², Eric M. Mortensen³ and Ishak Mansi⁴, ¹Rheumatology, San Antonio Military Medical Center, San Antonio, TX, ²Pharmacotherapy Education and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, ³Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, ⁴Internal Medicine, San Antonio Military Medical Center, San Antonio, TX
Background/Purpose: Due to their anti-inflammatory effects, statins were proposed to lower the incidence of connective tissue diseases (CTD). The objective of this study is to…
Abstract Number: 1043 • 2012 ACR/ARHP Annual Meeting
Assessment of Rheumatoid Arthritis Disease Activity by Power Doppler Ultrasonography: Association with Routine Clinical Indices and Its Usefulness in Detecting Remission
Hiroaki Taguchi, Kazuo Nishi, Takeo Kudo and Yutaka Okano, Division of Rheumatology, Department of Medicine, Kawasaki Municipal Kawasaki Hospital, Kawasaki, Japan
Background/Purpose: Power Doppler ultrasonography (PDUS) is sensitive for detecting synovitis in patients with rheumatoid arthritis (RA). We aimed to clarify the association of PDUS findings…
Abstract Number: 426 • 2012 ACR/ARHP Annual Meeting
Dickkopf-1 Stimulates Fibroblast-Like Synoviocyte Migration Through Janus Kinase Activation
Yubin Luo¹, Bryan Dieffenbach², Jung-Soo Song³, Jinseok Kim⁴, David L. Boyle⁵, Michael Karin⁶, Gary S. Firestein⁷ and Maripat Corr⁸, ¹Medicine, UCSD School of Medicine, La Jolla, CA, ²Medicine, UCSD School of Medicine, la Jolla, CA, ³Rheumatology, Chung-Ang University College of Medicine, Seoul, South Korea, ⁴Division of Rheumatology, Internal Medicine, Jeju National University Hospital, Jeju, Korea, South Korea, ⁵Div of Rheum, UCSD School of Medicine, La Jolla, CA, ⁶Departments of Pharmacology, UCSD School of Medicine, La Jolla, CA, ⁷Div of Rheumatology, UCSD School of Medicine, La Jolla, CA, ⁸Medicine, Univ of California-San Diego, La Jolla, CA
Background/Purpose: Wnt (wingless) pathway signaling has been implicated in patterning in embryogenesis and in adult wound healing and homeostasis. A canonical Wnt antagonist, Dickkopf-1 (DKK-1),…
Abstract Number: 73 • 2012 ACR/ARHP Annual Meeting
Trends in 21^stcentury Health Care Utilization in a Rheumatoid Arthritis Cohort Compared to the General Population
Sofia Hagel¹, Ingemar F. Petersson², Ann B. I. Bremander³, Elisabet Lindqvist⁴, Charlotte Bergknut⁵ and Martin Englund⁶, ¹Department of Clinical Sciences Lund, Section for Rheumatology, Lund, Lund University and Skåne University Hospital, Lund, Sweden, ²Lund University, Lund, Sweden, ³Department of Exercise Physiology, Biomechanics and Health, Halmstad University School of Business and Engineering,, Halmstad, Sweden, ⁴Department of Clinical Sciences, Lund, Section for Rheumatology, Lund, Lund University and Skåne University Hospital, Lund, Sweden, ⁵Department of Orthopedics, Lund University, Lund, Sweden, ⁶Department of Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden
Background/Purpose: To study twenty-first century trends in health care utilization by rheumatoid arthritis (RA) patients compared to the general population. Methods: Observational cohort study; using Swedish…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].